Primary Record
Lazertinib
- In stock
- 4,397 g
- Purity
- 99.4 %
- CAS
- 1903008-80-9
Compound Identifiers & Properties
- CAS
- 1903008-80-9
- PubChem CID
- 121269225
- SMILES
- CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC
- Canonical SMILES
- C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1
Names & Synonyms
- Lazertinib
- Lazcluze
- lazertinibum
- Leclaza
- 1903008-80-9
- Lazertinib?
- Lazertinib [USAN]
- Lazertinib [INN]
- GNS1480
- GNS-1480
- LAZERTINIB [INN]
- Lazertinib (USAN/INN)
- Lazertinib [USAN:INN]
- RefChem:798668
- JNJ-73841937-AAA
- YH-25448
- YH25448
- 4A2Y23XK11
- LAZERTINIB [WHO-DD]
- UNII-4A2Y23XK11
- orb1689983
- CHEMBL4558324
- SCHEMBL17670400
- GTPL10136
- RRMJMHOQSALEJJ-UHFFFAOYSA-N
- C-18112003-G
- C30H34N8O3
- DTXSID601376595
- GLXC-21722
- BCP30440
- DBD00880
- EX-A1912
- BDBM50555575
- MFCD31728331
- s8724
- WHO 10587
- AKOS037515597
- CCG-270023
- Lazertinib (YH25448,GNS-1480)
- YH-25448;GNS-1480
- AC-36243
- BP-43658
- BS-15742
- DA-74916
- YH 25448
- Compound 73 [WO2016060443A2]
- HY-109061
- AK00779508
- CS-0032992
- J3.766.889C
- N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide
- A16827
- D11980
- A903188
- N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide
- 2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-
- B0084-267741
- N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide
- YH-25448; YH 25448; YH25448; GNS-1480; GNS 1480; GNS1480
- Lazertinib; 2-Propenamide, N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phenyl]- (ACI); N-[5-[[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phen
- N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)acrylamide
- N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-(morpholin-4-yl)phenyl)prop-2-enamide
- N-(5-((4-(4-((dimethylamino)methyl)-3-phenylpyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholin-4-ylphenyl)prop-2-enamide
- N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide
- N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-pyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholino-phenyl]prop-2-enamide
- N-{5-[(4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl)amino]-4-methoxy-2-(morpholin-4-yl)phenyl}prop-2-enamide
- N-5-[[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholinophenyl]acrylamide